Literature DB >> 9520380

Crystal structure of MTCP-1: implications for role of TCL-1 and MTCP-1 in T cell malignancies.

Z Q Fu1, G C Du Bois, S P Song, I Kulikovskaya, L Virgilio, J L Rothstein, C M Croce, I T Weber, R W Harrison.   

Abstract

Two related oncogenes, TCL-1 and MTCP-1, are overexpressed in T cell prolymphocytic leukemias as a result of chromosomal rearrangements that involve the translocation of one T cell receptor gene to either chromosome 14q32 or Xq28. The crystal structure of human recombinant MTCP-1 protein has been determined at 2.0 A resolution by using multiwavelength anomalous dispersion data from selenomethionine-enriched protein and refined to an R factor of 0.21. MTCP-1 folds into a compact eight-stranded beta barrel structure with a short helix between the fourth and fifth strands. The topology is unique. The structure of TCL-1 has been predicted by molecular modeling based on 40% amino acid sequence identity with MTCP-1. The identical residues are clustered inside the barrel and on the surface at one side of the barrel. The overall structure of MTCP-1 superficially resembles the structures of proteins in the lipocalin family and calycin superfamily. These proteins have diverse functions, including transport of retinol, fatty acids, chromophores, pheromones, synthesis of prostaglandin, immune modulation, and cell regulation. However, MTCP-1 differs in the topology of the beta strands. The structural similarity suggests that MTCP-1 and TCL-1 form a unique family of beta barrel proteins that is predicted to bind small hydrophobic ligands and function in cell regulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520380      PMCID: PMC19850          DOI: 10.1073/pnas.95.7.3413

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

2.  Purification and characterization of recombinant forms of TCL-1 and MTCP-1 proteins.

Authors:  G C Du Bois; S P Song; I Kulikovskaya; L Virgilio; J Varnum; M W Germann; C M Croce
Journal:  Protein Expr Purif       Date:  1998-03       Impact factor: 1.650

3.  The salivary lipocalin von Ebner's gland protein is a cysteine proteinase inhibitor.

Authors:  W van't Hof; M F Blankenvoorde; E C Veerman; A V Amerongen
Journal:  J Biol Chem       Date:  1997-01-17       Impact factor: 5.157

4.  Sequence analysis, cellular localization, and expression of a neuroretina adhesion and cell survival molecule.

Authors:  P Berman; P Gray; E Chen; K Keyser; D Ehrlich; H Karten; M LaCorbiere; F Esch; D Schubert
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

5.  Role of chromosome translocations in human neoplasia.

Authors:  C M Croce
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

6.  Identification of the TCL1 gene involved in T-cell malignancies.

Authors:  L Virgilio; M G Narducci; M Isobe; L G Billips; M D Cooper; C M Croce; G Russo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

7.  Three-dimensional structure of recombinant human muscle fatty acid-binding protein.

Authors:  G Zanotti; G Scapin; P Spadon; J H Veerkamp; J C Sacchettini
Journal:  J Biol Chem       Date:  1992-09-15       Impact factor: 5.157

8.  Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas.

Authors:  S P Stoesz; M N Gould
Journal:  Oncogene       Date:  1995-12-07       Impact factor: 9.867

9.  TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia.

Authors:  M G Narducci; L Virgilio; M Isobe; A Stoppacciaro; R Elli; M Fiorilli; M Carbonari; A Antonelli; L Chessa; C M Croce; G Russo
Journal:  Blood       Date:  1995-09-15       Impact factor: 22.113

10.  Crystallization of a fragment of human fibronectin: introduction of methionine by site-directed mutagenesis to allow phasing via selenomethionine.

Authors:  D J Leahy; H P Erickson; I Aukhil; P Joshi; W A Hendrickson
Journal:  Proteins       Date:  1994-05
View more
  10 in total

1.  Prioritizing genes for X-linked diseases using population exome data.

Authors:  Xiaoyan Ge; Pui-Yan Kwok; Joseph T C Shieh
Journal:  Hum Mol Genet       Date:  2014-09-12       Impact factor: 6.150

2.  Genomic analysis of human and mouse TCL1 loci reveals a complex of tightly clustered genes.

Authors:  C Hallas; Y Pekarsky; T Itoyama; J Varnum; R Bichi; J L Rothstein; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

3.  Backbone dynamics and solution structure refinement of the 15N-labeled human oncogenic protein p13MTCP1: comparison with X-ray data.

Authors:  L Guignard; A Padilla; J Mispelter; Y S Yang; M H Stern; J M Lhoste; C Roumestand
Journal:  J Biomol NMR       Date:  2000-07       Impact factor: 2.835

4.  Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes.

Authors:  Y Pekarsky; C Hallas; M Isobe; G Russo; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.

Authors:  Marco Herling; Kaushali A Patel; Michael A Teitell; Marina Konopleva; Farhad Ravandi; Ryuji Kobayashi; Dan Jones
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

6.  Tcl1 enhances Akt kinase activity and mediates its nuclear translocation.

Authors:  Y Pekarsky; A Koval; C Hallas; R Bichi; M Tresini; S Malstrom; G Russo; P Tsichlis; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

7.  A virtual pebble game to ensemble average graph rigidity.

Authors:  Luis C González; Hui Wang; Dennis R Livesay; Donald J Jacobs
Journal:  Algorithms Mol Biol       Date:  2015-03-18       Impact factor: 1.405

8.  Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia.

Authors:  Janek S Walker; Zachary A Hing; Steven Sher; James Cronin; Katie Williams; Bonnie Harrington; Jordan N Skinner; Casey B Cempre; Charles T Gregory; Alexander Pan; Max Yano; Larry P Beaver; Brandi R Walker; Jadwiga M Labanowska; Nyla A Heerema; Krzysztof Mrózek; Jennifer A Woyach; Amy S Ruppert; Amy Lehman; Hatice Gulcin Ozer; Vincenzo Coppola; Pearlly Yan; John C Byrd; James S Blachly; Rosa Lapalombella
Journal:  Nat Commun       Date:  2021-11-03       Impact factor: 14.919

9.  Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).

Authors:  P Jain; E Aoki; M Keating; W G Wierda; S O'Brien; G N Gonzalez; A Ferrajoli; N Jain; P A Thompson; E Jabbour; R Kanagal-Shamanna; S Pierce; A Alousi; C Hosing; I Khouri; Z Estrov; J Cortes; H Kantarjian; F Ravandi; T M Kadia
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

10.  TCL1 participates in early embryonic development and is overexpressed in human seminomas.

Authors:  Maria Grazia Narducci; Maria Teresa Fiorenza; Sang-Moo Kang; Arturo Bevilacqua; Monica Di Giacomo; Daniele Remotti; Maria Cristina Picchio; Vincenzo Fidanza; Max D Cooper; Carlo Maria Croce; Franco Mangia; Giandomenico Russo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.